摘要 |
Compositions and methods useful for targeted depletion or modulation of dendritic cells are provided. The compositions and methods can be used to promote healing of ischemia-related injury, including ischemia-reperfusion injury. Disclosed are a variety of dendritic cell-targeted toxins, bone morphogenetic protein 7 (BMP7) agonists, and dendritic cell-targeted transforming growth factor beta 1 (TGF-ßl) antagonists, all useful in practicing methods of the invention. The inventive compositions and methods can be used in the treatment of various conditions including myocardial infarction, stroke, and critical limb ischemia. |
申请人 |
CELDARA MEDICAL, LLC;DE MUINCK, EBO, D.;CONEJO-GARCIA, JOSE, R. |
发明人 |
DE MUINCK, EBO, D.;CONEJO-GARCIA, JOSE, R. |